bpc-157 fda warning 2024 mulls compounding for peptides previously flagged over safety risks 💊FDA Approval Update | #FDA

The incidence of BPI has been increasing

Meanwhile, the Adelaide University medical researcher who led the six clinical trials from 2001 to 2007 has expressed his regret that the ''negative data'' was not published soon after the trial was completed

The outcome will determine whether these peptides can continue to be compounded and prescribed through licensed 503A pharmacies in the US

doi: 10.34172/hpp.2020.18 2 ShamoonHDuffyHFleischerNEngelSSaengerPStrelzynMet al

Most protocols recommend a 24 week break after a cycle to reassess progress and prevent diminishing returns

However, many people are deficient in this important vitamin due to dietary restrictions, medical conditions, or absorption issues